Comprehensive cancer-related gene analysis reveals that active KRAS mutation is a prognostic mutation in mycosis fungoides

J Dermatol Sci. 2017 Dec;88(3):367-370. doi: 10.1016/j.jdermsci.2017.07.013. Epub 2017 Jul 17.

Affiliations

¹ Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Electronic address: yanagi@med.hokudai.ac.jp.
² Laboratory of Translational Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
³ Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

PMID: 28754405
DOI: 10.1016/j.jdermsci.2017.07.013

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Biopsy
DNA Mutational Analysis
Fatal Outcome
Humans
Male
Middle Aged
Mutation
Mycosis Fungoides / genetics*
Mycosis Fungoides / pathology
Prognosis
Proto-Oncogene Proteins p21(ras) / genetics*
Skin / pathology
Skin Neoplasms / genetics*
Skin Neoplasms / pathology

Substances

KRAS protein, human
Proto-Oncogene Proteins p21(ras)